DE602004002696T2 - Neue 14- und 15-gliedrige ringverbindungen - Google Patents

Neue 14- und 15-gliedrige ringverbindungen Download PDF

Info

Publication number
DE602004002696T2
DE602004002696T2 DE602004002696T DE602004002696T DE602004002696T2 DE 602004002696 T2 DE602004002696 T2 DE 602004002696T2 DE 602004002696 T DE602004002696 T DE 602004002696T DE 602004002696 T DE602004002696 T DE 602004002696T DE 602004002696 T2 DE602004002696 T2 DE 602004002696T2
Authority
DE
Germany
Prior art keywords
alkyl
hydrogen
optionally substituted
ethyl
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004002696T
Other languages
German (de)
English (en)
Other versions
DE602004002696D1 (de
Inventor
Pliva Sulejman ALIHODZIC
GlaxoSmithKline Andrew Keith FORREST
GlaxoSmithKline Richard Lewis JARVEST
Pliva Gorjana LAZAREVSKI
Pliva Drazen PAVLOVIC
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Fidelta doo
Original Assignee
Glaxo Group Ltd
GlaxoSmithKline Istrazivacki Centar Zagreb doo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, GlaxoSmithKline Istrazivacki Centar Zagreb doo filed Critical Glaxo Group Ltd
Publication of DE602004002696D1 publication Critical patent/DE602004002696D1/de
Application granted granted Critical
Publication of DE602004002696T2 publication Critical patent/DE602004002696T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE602004002696T 2003-05-13 2004-05-11 Neue 14- und 15-gliedrige ringverbindungen Expired - Lifetime DE602004002696T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0310986.5A GB0310986D0 (en) 2003-05-13 2003-05-13 Novel compounds
GB0310986 2003-05-13
PCT/EP2004/005082 WO2004101586A1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 membered-ring compounds

Publications (2)

Publication Number Publication Date
DE602004002696D1 DE602004002696D1 (de) 2006-11-16
DE602004002696T2 true DE602004002696T2 (de) 2007-08-16

Family

ID=9957984

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004002696T Expired - Lifetime DE602004002696T2 (de) 2003-05-13 2004-05-11 Neue 14- und 15-gliedrige ringverbindungen

Country Status (22)

Country Link
US (1) US7569550B2 (enExample)
EP (1) EP1628988B1 (enExample)
JP (1) JP2007502313A (enExample)
KR (1) KR20060026407A (enExample)
CN (1) CN1849328A (enExample)
AR (1) AR044309A1 (enExample)
AT (1) ATE341560T1 (enExample)
AU (1) AU2004238528A1 (enExample)
BR (1) BRPI0410246A (enExample)
CA (1) CA2525452A1 (enExample)
CL (1) CL2004001010A1 (enExample)
DE (1) DE602004002696T2 (enExample)
DK (1) DK1628988T3 (enExample)
ES (1) ES2273255T3 (enExample)
GB (1) GB0310986D0 (enExample)
HR (1) HRP20060448T3 (enExample)
MX (1) MXPA05012163A (enExample)
PL (1) PL1628988T3 (enExample)
PT (1) PT1628988E (enExample)
RU (1) RU2005134908A (enExample)
WO (1) WO2004101586A1 (enExample)
ZA (1) ZA200509079B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007054295A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited New 4*-substituted erythromycin derivative
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
US8080529B2 (en) 2005-01-13 2011-12-20 Glaxo Group Limited Macrolides with anti-inflammatory activity
JP2008540503A (ja) 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用なエーテル結合マクロライド
WO2007054296A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited Macrolones
MX2011008074A (es) 2009-01-30 2011-08-17 Glaxo Group Ltd Macrolido anti-inflamatorio.
CN111574575B (zh) * 2020-04-29 2022-05-17 北京理工大学 一种含有大环内酯基的喹喏酮衍生物、制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0465581B1 (en) * 1989-03-28 1995-10-04 Abbott Laboratories Erythromycin derivatives
AU3710695A (en) * 1995-04-27 1996-11-18 Laboratorios Aranda, S.A. De C.V. Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them
AU710532B2 (en) * 1996-05-07 1999-09-23 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
JP4311203B2 (ja) * 2001-08-08 2009-08-12 大正製薬株式会社 11a−アザライド化合物及びその製造方法
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
AR044309A1 (es) 2005-09-07
US7569550B2 (en) 2009-08-04
US20070185117A1 (en) 2007-08-09
GB0310986D0 (en) 2003-06-18
RU2005134908A (ru) 2006-06-27
WO2004101586A1 (en) 2004-11-25
PT1628988E (pt) 2007-01-31
BRPI0410246A (pt) 2006-05-16
PL1628988T3 (pl) 2007-03-30
ES2273255T3 (es) 2007-05-01
ZA200509079B (en) 2007-02-28
CA2525452A1 (en) 2004-11-25
KR20060026407A (ko) 2006-03-23
JP2007502313A (ja) 2007-02-08
ATE341560T1 (de) 2006-10-15
EP1628988A1 (en) 2006-03-01
MXPA05012163A (es) 2006-05-19
CN1849328A (zh) 2006-10-18
CL2004001010A1 (es) 2005-03-18
DE602004002696D1 (de) 2006-11-16
DK1628988T3 (da) 2007-02-05
AU2004238528A1 (en) 2004-11-25
EP1628988B1 (en) 2006-10-04
HRP20060448T3 (hr) 2007-03-31

Similar Documents

Publication Publication Date Title
DE60220180T2 (de) 14 bis 15 gliedrige makrolide mit antibakterieller aktivität
DE60123277T2 (de) Makrolidantibiotika
EP1469008B1 (en) Method of preparing a non-pharmaceutical grade clarithromycin
DE602004003809T2 (de) Neue 14- und 15-gliedrige ringverbindungen
KR20070085919A (ko) 마크로론 - 아미노 치환된 퀴놀론
DE602004002696T2 (de) Neue 14- und 15-gliedrige ringverbindungen
DE69217398T2 (de) Verfahren zur Herstellung von 9-deoxo-9(z)-hydroxyiminoerythromycin A
MXPA06012923A (es) Macrolidos asociados a ester utiles para el tratamiento de infecciones microbianas.
JP2008519787A (ja) マクロロン化合物
DE602004010110T2 (de) Neue 14- und 15-gliedrige ringverbindungen
DE60005334T2 (de) 6-o-carbamat ketolide derivate
JP2008540503A (ja) 細菌感染症の処置に有用なエーテル結合マクロライド
JP2006528947A (ja) 4”−置換マクロライド
JP2007500193A (ja) 新規な14−及び15−員環化合物
WO2004101589A1 (en) Novel 14 and 15 membered-ring compounds
EP1824871A1 (en) Macrolone compounds
JP2007536372A (ja) 微生物感染症の治療に有用なカルバミン酸エステル結合マクロライド
EP1879904A1 (en) 4" amino linked macrolides useful for the treatment of microbial infections
JP2008519789A (ja) マクロロン化合物

Legal Events

Date Code Title Description
8364 No opposition during term of opposition